Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. [electronic resource]
Producer: 20141028Description: e84940 p. digitalISSN:- 1932-6203
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Disease Progression
- Female
- Fluorouracil -- administration & dosage
- Gene Frequency
- Genetic Variation
- Genotype
- HLA Antigens -- classification
- HLA-B Antigens -- genetics
- Humans
- Irinotecan
- Kaplan-Meier Estimate
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Metastasis
- Prognosis
- Receptors, KIR -- classification
- Receptors, KIR3DL1 -- genetics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.